Cobalt protoporphyrin as a potential therapeutic agent? [1]

FASEB Journal

Volumn 21, Issue 11, 2007, Pages 2639-

  Schmidt, Rene ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; HEME OXYGENASE 1; ISOFLURANE; PORPHYRIN COBALT; PROTEIN BACH1; PROTOPORPHYRIN; SEVOFLURANE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ASTHMA; CELL CULTURE; CERULOPLASMIN BLOOD LEVEL; COPPER METABOLISM; DISEASE SEVERITY; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; UPREGULATION;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HUMANS; NF-E2-RELATED FACTOR 2; PROTOPORPHYRINS;

EID: 34548503871     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-0904ltr     Document Type: Letter

References (9)

1. Shan, Y., Lambrecht, R. W., Donohue, S. E., and Bonkovsky, H. L. (2006) Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J. 20, 2651-2653
2. Ryter, S. W., Alam, J., and Choi, A. M. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650
3. Galbraith, R. A., and Kappas, A. (1989) Regulation of food intake and body weight by cobalt porphyrins in animals. Proc. Natl. Acad. Sci. U.S.A. 86, 7653-7657
4. Muhoberac, B. B., Hanew, T., Halter, S., and Schenker, S. (1989) A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration. Biochem. Pharmacol. 38, 4103-4113
5. Rosenberg, D. W., and Kappas, A. (1995) The comparative abilities of inorganic cobalt and cobalt-protoporphyrin to affect copper metabolism and elevate plasma ceruloplasmin. Pharmacology 50, 201-208
6. Smith, T. J., Drummond, G. S., and Kappas, A. (1987) Cobalt- protoporphyrin suppresses thyroid and testicular hormone concentrations in rat serum: a novel action of this synthetic heme analogue. Pharmacology 34, 9-16
7. Hoetzel, A., Geiger, S., Loop, T., Welle, A., Schmidt, R., Humar, M., Pahl, H. L., Geiger, K. K., and Pannen, B. H. (2002) Differential effects of volatile anesthetics on hepatic heme oxygenase-1 expression in the rat. Anesthesiology 97, 1318-1321
8. Schmidt, R., Tritschler, E., Hoetzel, A., Loop, T., Humar, M., Halverscheid, L., Geiger, K. K., and Pannen, B. H. J. (2007) Isofluorane pretreatment protects rat livers from ischemia/reperfusion injury by induction of heme oxygenase-1. Ann. Surg. 245, 931-942
9. Schmidt, R., Hoetzel, A., Baechle, T., Loop, T., Humar, M., Bauer, M., Pahl, H. L., Geiger, K. K., and Pannen, B. H. (2004) Isoflurane pretreatment lowers portal venous resistance by increasing hepatic heme oxygenase activity in the rat liver in vivo. J. Hepatol. 41, 706-713